Education
About Us
Working with TipRanks
Follow Us
Anthera Pharmaceuticals (ANTH)
OTHER OTC:ANTH
| Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -281.00K |
| Operating Income | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -36.43M |
| EBITDA | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -26.59M |
| Net Income | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -16.93M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 2.20M |
| Total Assets | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 3.67M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -2.20M |
| Total Liabilities | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 9.17M |
| Stockholders' Equity | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -5.50M |
| Cash Flow | |||||
| Free Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -36.90M |
| Operating Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -36.90M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 18.25M |
Anthera Pharmaceuticals Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.